Condition: Tricuspid Valve Regurgitation · Heart Valve Disease · Cardiovascular Diseases · Sponsor: TRiCares
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
This description comes directly from the study's public registry record.
Esther Gerteis · +41796015318 · gerteis@tricares.de
Always discuss trial participation with your own doctor first.
| Algemeen Stedelijk Ziekenhuis | Aalst, Belgium | Recruiting |
| ZNA Middelheim | Antwerp, Belgium | Recruiting |
| UZ Brussel | Brussels, Belgium | Recruiting |
| Cliniques Universitaires Saint-Luc UCL | Brussels, Belgium | Recruiting |
| Centre hospitalier universitaire CHU de Liège | Liège, Belgium | Not Yet Recruiting |
| AZ Delta | Roeselare, Belgium | Recruiting |
| University Medical Center of the Johannes Gutenberg University Mainz | Mainz, Germany | Not Yet Recruiting |
| Ludwig Maximilian University Hospital | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06581471